Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Business Times.
Press releases published on April 15, 2025
![[Latest] Global Transformer Core Market Size/Share Worth USD 12.7 Billion by 2034 at a 3.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)](/images/pressrelease-small.png)
[Latest] Global Transformer Core Market Size/Share Worth USD 12.7 Billion by 2034 at a 3.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
GlobeNewswire
·
April 15, 2025
Austin, TX, USA, April 15, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Transformer Core Market Size, Trends, and Insights” that covers various aspects like product types (Distribution Transformer, Power …
Oculis Hosts R&D Event Today to Showcase Progress on All Three Pipeline Assets
GlobeNewswire
·
April 15, 2025
ZUG, Switzerland, April 15, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company"), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant …
Integral Metals Responds to China’s Rare Earth Export Restrictions, Advancing Exploration at North American Properties
GlobeNewswire
·
April 15, 2025
CALGARY, Alberta, April 15, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) recognizes the recent decision by China’s Ministry of Commerce and the General Administration of Customs to …
Cue Biopharma Announces Pricing of Approximately $20 Million Public Offering
GlobeNewswire
·
April 15, 2025
BOSTON, April 14, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of …